Cigna Group (CI) vs Humana (HUM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Humana (HUM) has outperformed Cigna Group (CI) over the past year, gaining 34.3% versus a loss of 9.3%. Over five years, CI leads with a +36.8% price change compared with -7.7% for HUM. Cigna Group is the larger company by market cap ($73.59 billion vs $47.61 billion), about 1.5 times the size.
On valuation, Cigna Group trades at a lower forward P/E (8.3x vs 23.9x for Humana). Cigna Group offers the higher dividend yield (2.20% vs 0.89%). Cigna Group converts more of its revenue into profit, with a net margin of 2.2% versus 0.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CI | HUM |
|---|---|---|
| Share price | $278.51 | $396.51 |
| Market cap | $73.59B | $47.61B |
| 1-day change | +1.51% | -1.92% |
| YTD return | +1.19% | +54.81% |
| 1-year return | -9.32% | +34.30% |
| 5-year return | +36.83% | -7.71% |
| P/E ratio (TTM) | 11.51 | 37.48 |
| Forward P/E | 8.31 | 23.90 |
| EPS (TTM) | $24.19 | $10.58 |
| Dividend yield | 2.20% | 0.89% |
| Annual dividend | $6.14 | $3.54 |
| Revenue (latest FY) | $274.90B | $129.66B |
| Revenue growth (YoY) | +11.24% | +10.11% |
| Net income (latest FY) | $5.96B | $1.19B |
| Gross margin | 21.79% | — |
| Operating margin | 3.35% | 2.09% |
| Net margin | 2.17% | 0.92% |
| 52-week high | $312.18 | $428.88 |
| 52-week low | $239.51 | $163.11 |
| Distance from 52-week high | -10.79% | -7.55% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +22.90% | +6.87% |
| Average volume | 1.67M | 1.23M |
| Shares outstanding | 264.24M | 120.08M |
| Employees | 65,669 | 67,060 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HUM has outperformed CI by 43.6 percentage points over the past year.
- Humana trades at a higher earnings multiple (37.5x vs 11.5x trailing P/E).
- Cigna Group offers a meaningfully higher dividend yield (2.20% vs 0.89%).
About Cigna Group
CI stock →The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.
Health Care · Medical Specialities · 65,669 employees
About Humana
HUM stock →Humana Inc. provides medical and specialty insurance products in the United States.
Health Care · Medical Specialities · 67,060 employees
CI vs HUM FAQ
Which is bigger, Cigna Group or Humana?
Cigna Group (CI) is larger, with a market capitalization of $73.59B compared with $47.61B for Humana (HUM).
Which stock has performed better over the past year, CI or HUM?
HUM returned +34.30% over the past 12 months, compared with -9.32% for CI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CI or HUM?
CI has the lower trailing P/E at 11.5, versus 37.5 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cigna Group or Humana?
Cigna Group has the higher yield at 2.20%, compared with 0.89% for Humana.
Are Cigna Group and Humana in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.